Research advances in the role and mechanism of peroxisome proliferator-activated receptor alpha in liver diseases / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 2351-2354, 2019.
Article
Dans Chinois
| WPRIM
| ID: wpr-778750
ABSTRACT
Peroxisome proliferator-activated receptor alpha (PPARα) is a member of the nuclear receptor superfamily and plays a central regulatory role in lipid metabolism. Recent studies have found that PPARα agonists play a key role in the prevention and treatment of nonalcoholic fatty liver disease, which has also been reported in other liver diseases. This article reviews the role and mechanism of PPARα in nonalcoholic fatty liver disease, alcoholic liver disease, viral hepatitis, cholestatic liver disease, drug-induced liver injury, and hepatocellular carcinoma, so as to provide a reference for the research on the new application of conventional drugs associated with PPARα.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Journal of Clinical Hepatology
Année:
2019
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS